GILEAD SCIENCES, INC.

Q4 2025 13F-HR Holdings

Location
Foster City, CA
Holdings as of
12/31/2025
Date filed
2/12/2026
Form type
13F-HR
Num holdings
6
Total value ($000)
$1,935,508
Net value change ($000)
+144,041 (8.0%)
New positions
0
Sold out positions
3
Turnover %
4.4%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 11/13/2025 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q3 2025
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
RCUS 321,475 75.2%
ASMB 37,890 32.9%
KYTX 14,029 56.7%
Top Reduces (Value $000, Stocks/ETFs)
ACLX -113,582 -20.6%
Merus N.V. -42,605 -100.0%
TNGX -40,777 -100.0%
GLPG -28,131 -4.9%
CYPH -2,415 -100.0%
XLO -1,844 -24.0%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type